Company	StageDateRound Size	Total Raised
SmithRx	Series CJan 2024$60M Series BMar 2022$27M	$100M
Co-investors: Darian Shirazi (Gradient Ventures), Fabian Hansen (Presight Capital), Henry McNamara (Great Oaks Venture Capital), Bob Kocher (Venrock), Louis Beryl, Konstantin von Unger, Zachary Hargreaves
Mythic Therapeutics	Series BDec 2021$100M	$100M
Co-investors: Josh Kopelman (First Round Capital)
Stride Health	Series COct 2021$47M Series BAug 2017$24M Series AMay 2015$13M	$86M
Co-investors: Carl Byers (F-Prime Capital Partners), Bob Kocher (Venrock), Constance Freedman (Moderne Ventures), Jonathan Bush, Kevin Nazemi
Element Biosciences	Series CJun 2021$280M	$280M
Co-investors: Jim Tananbaum (Foresite Capital)
The Public Health Company	SeedApr 2021$8M	$8M
Federation Bio	Series AOct 2020$50M	$50M
Co-investors: Racquel Bracken (Venrock)
Lyra Health	Series CMar 2020$75M Series UnknownMay 2018$65M Series AOct 2015$35M SeedJun 2015$3M	$520M
Co-investors: James Slavet (Greylock), Somesh Dash (IVP), Marc Stad (Dragoneer Investment Group), Stewart Gollmer (Tenaya Capital), Bob Kocher (Venrock), Paul George, Howard Schultz
Kyruus	Series DJan 2020$42M Corporate RoundApr 2018$10M Series CSep 2015$25M Series BJan 2013$11M Series AJun 2011$8M	$96M
Co-investors: Carl Byers (F-Prime Capital Partners), Jonathan Bush

Bryan Roberts